Cargando…
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience
INTRODUCTION: Whether biologic therapies enhance the risk of coronavirus 2019 (COVID-19) or affect the disease outcome in patients with chronic plaque psoriasis remains to be ascertained. OBJECTIVE: We sought to investigate the incidence of hospitalization and death for COVID-19 in a large sample of...
Autores principales: | Gisondi, Paolo, Piaserico, Stefano, Naldi, Luigi, Dapavo, Paolo, Conti, Andrea, Malagoli, Piergiorgio, Marzano, Angelo Valerio, Bardazzi, Federico, Gasperini, Massimo, Cazzaniga, Simone, Costanzo, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644231/ https://www.ncbi.nlm.nih.gov/pubmed/33160968 http://dx.doi.org/10.1016/j.jaci.2020.10.032 |
Ejemplares similares
-
Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy
por: Piaserico, Stefano, et al.
Publicado: (2020) -
Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs
por: Gisondi, Paolo, et al.
Publicado: (2021) -
Assessing the Risk and Outcome of COVID-19 in Patients with Psoriasis or Psoriatic Arthritis on Biologic Treatment: A Critical Appraisal of the Quality of the Published Evidence
por: Piaserico, Stefano, et al.
Publicado: (2022) -
Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study
por: GNESOTTO, Laura, et al.
Publicado: (2023) -
Results of COVID-19 screening in a dermatologic clinic in Northern Italy
por: BURLANDO, MARTINA, et al.
Publicado: (2023)